Skip to main content
Premium Trial:

Request an Annual Quote

Illumina: Jan 17, 2003


Illumina to Open Japanese Subsidiary; European, US Headcounts to Grow

Illumina will open a subsidiary in Japan by mid-January and bolster its sales and services forces in Europe and the US to sell its new integrated genotyping system, the company said.

CEO Jay Flatley said Illumina has already hired a president for the subsidiary, but declined to name the individual until he resigns from his current post at another company. Illumina, which is based in San Diego, will also have four “pretty high-horsepower guys” in Japan by the end of January and six by the end of the year to sell the new system, oligos, and other applications, Flatley said.

In addition, Illumina intends to put seven or eight staffers on the ground in Europe by the end of 2003. Lastly, the six people who currently sell and service the massive genotyping system in the US can expect four new faces by the end of the year.

Flatley said there are between 20 and 30 customers for Illumina’s genotyping platform, which became available at the end of 2002 at a cost of between $1.5 million and $2 million.

The unit, modeled after the BeadArray-based system Illumina now employs in its scientific operations facility, comprises LIMS software and licenses, BeadArray operating software, robots, confocal scanning equipment, and assay protocols for high-throughput operations.

There are two versions of the system — one that churns out a million genotypes a day and one that does 600,000 — which Flatley said will be targeted to “large pharmaceutical companies … and large research centers that are involved in large genotyping projects, like the haplotype map. And there’s many large government-funded projects coming online now to do genotyping on a large scale.”

“We are in late-stage discussions with a number of potential customers,” said Flatley, who promises to announce the first deal sometime over the next three months.

— KL

Filed under

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.